Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88351275 | 8835127 | 5 | F | 201101 | 20160908 | 20121011 | 20160912 | EXP | CA-ROCHE-775831 | ROCHE | 47.71 | YR | M | Y | 55.00000 | KG | 20160912 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88351275 | 8835127 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | NOT PROVIDED | 125276 | 188.8 | MG | SOLUTION FOR INFUSION | ||||||
| 88351275 | 8835127 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | NOT PROVIDED | 125276 | 377.6 | MG | SOLUTION FOR INFUSION | ||||||
| 88351275 | 8835127 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | NOT PROVIDED | 125276 | 188.8 | MG | SOLUTION FOR INFUSION | ||||||
| 88351275 | 8835127 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | NOT PROVIDED | 125276 | 188 | MG | SOLUTION FOR INFUSION | ||||||
| 88351275 | 8835127 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | NOT PROVIDED | 125276 | 200 | MG | SOLUTION FOR INFUSION | ||||||
| 88351275 | 8835127 | 6 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 88351275 | 8835127 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 88351275 | 8835127 | 8 | C | COUMADIN | WARFARIN SODIUM | 1 | 0 | ||||||||||||
| 88351275 | 8835127 | 9 | C | ACTONEL | RISEDRONATE SODIUM | 1 | 0 | ||||||||||||
| 88351275 | 8835127 | 10 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 88351275 | 8835127 | 11 | C | ALTACE | RAMIPRIL | 1 | 0 | ||||||||||||
| 88351275 | 8835127 | 12 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 | ||||||||||||
| 88351275 | 8835127 | 13 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 88351275 | 8835127 | 14 | C | PREDNISONE. | PREDNISONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 88351275 | 8835127 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 88351275 | 8835127 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 88351275 | 8835127 | Flushing | |
| 88351275 | 8835127 | Hypotension | |
| 88351275 | 8835127 | Inguinal hernia | |
| 88351275 | 8835127 | Malaise | |
| 88351275 | 8835127 | Migraine | |
| 88351275 | 8835127 | Nasopharyngitis | |
| 88351275 | 8835127 | Pharyngitis streptococcal | |
| 88351275 | 8835127 | Pneumonia | |
| 88351275 | 8835127 | Sluggishness | |
| 88351275 | 8835127 | Weight decreased | |
| 88351275 | 8835127 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |